| Document Date: 2014-03-19 09:07:42
Open Document File Size: 171,93 KBShare Result on Facebook
Company CVs / Clinical Chemistry (EC4) Working Group / / Event Product Issues / / IndustryTerm detection systems / test protocol / diagnostic tools / defective heparin-binding site / / MedicalCondition Purpura / arterial thrombosis / thrombophilia / I deficiency / severe liver diseases / thrombophilia marker / cancer / Disease / disseminated intravascular coagulation / homozygous deficiency / heterozygous deficiency / post-phlebitic syndrome / XII deficiency / venous thrombosis / S free antigen deficiency / arterial ischemic stroke / moderate hyperhomocysteinemia / familial thrombotic diseases / non-Leiden APC resistance / peripheral venous thrombosis / II deficiency / HELLP syndrome / C deficiency / nephrotic syndrome / inherited thrombophilia call / Venous intracranial thrombosis / inherited disorders / hereditary defects / APC resistance / Activated Protein C Resistance / venous thromboembolism / inherited thrombophilias / respiratory and cardiovascular diseases / inherited deficiency / deficiency / recurrent idiopathic thrombosis / Hyperhomocysteinemia / thrombophilia screening / thrombosis / Liver disease / inflammatory diseases / S deficiency / inherited thrombophilia / / MedicalTreatment oral contraceptives / hormonal therapy / surgery / hormone replacement therapy / / Organization World Health Organization / FIRST LEVEL CLINICAL LABORATORIES European Community Confederation of Clinical Chemistry / / Person Paolo Simioni / Jarkko Ihalainen / / Position calibrator / / Product polyethylene glycol / heparin-binding site / / Technology electrophoresis / diagnostic tests / antibodies / genotyping / test protocol / /
SocialTag |
GUIDELINES FOR THE LABORATORY INVESTIGATION OF INHERITED THROMBOPHILIAS RECOMMENDATIONS FOR FIRST LEVEL CLINICAL LABORATORIES European Community Confederation of Clinical Chemistry (EC4) Working Group on Guidelines for I